Drug Bioavailability

By Hugo Kubinyi, Raimund Mannhold, Gerd Folkers, et al.

The gold standard for industrial research now completely revised in line with current trends in the field, with all contributions extensively updated or rewritten.
In 21 chapters readers can benefit from the key working knowledge of today's leading pharmaceutical companies, including Pfizer, AstraZeneca, and Roche. Drug developers from industry and academia present all the factors governing drug bioavailability, complete with practical examples and real-life data.
Part I focuses on in vitro and in vivo measurements of physicochemical properties, such as membrane permeability and ionization. Part II discusses solubility and gastrointestinal absorption, while the third part is devoted to metabolism and excretory mechanisms. The much revised and expanded part IV surveys current in silico approaches to predict drug properties needed to estimate the bioavailability of any new drug candidate. The final part shows how poor bioavailability may be improved by various approaches during the development process.
No other publication offers the same level of treatment on this crucial topic in modern drug development.

• Format: Hardcover
• Language: English
• ISBN: 3527320512
• ISBN13: 9783527320516
• Release Date: December 2008
• Publisher: Wiley-Vch
• Length: 649 Pages
• Weight: 3.00 lbs.
• Dimensions: 1.5" x 7.1" x 9.5"